期刊
AIDS
卷 22, 期 14, 页码 1699-1703出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0b013e3283021a61
关键词
HIV vaccine; protective immunity; recombinant viral vectors; T cells
资金
- European Union
- Dutch AIDS Fund
- LSBR
- UMC Utrecht
In September 2007, it was announced that the most promising HIV vaccine trial had to be stopped because it had failed to show the protection that was hoped for. Here, the history of HIV vaccine development from the discovery of HIV-1 in 1983 until 2008, the underlying ideas on protective immunity to HIV and potential avenues for vaccine research are discussed. (C) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据